Healthcare spending set to reach 159 billion but remains at 6.4 per cent of GDP, with pressure set to come from care for the non-self-sufficient
Sustainability will depend not only on the quantity of resources but also on the ability to adapt the organisation and its staff to meet the care needs of the most vulnerable
Key points
More billions for the health service, but without an increase in its share of the economy in the short term, whilst in the long term, an ageing population and a rise in those requiring care are set to profoundly shift the demand for care.
This is the picture that emerges from the State General Accounting Office’s report, ‘Medium- to long-term trends in the pension and social care systems – 2026 update’, which has just been published and which sets out the trend in healthcare and social care expenditure up to 2070.
The painting
In 2025, public healthcare expenditure stood at 141.5 billion, equivalent to 6.3 per cent of GDP, representing a 2.5 per cent increase on the previous year – lower than the 4.1 per cent rise indicated in earlier forecasts. In 2026, however, a much sharper rise is forecast: 148.5 billion, up 4.9 per cent, with the share of GDP rising to 6.4 per cent. However, between now and 2029, that percentage will remain unchanged: expenditure will reach 151.2 billion in 2027, 155.1 billion in 2028 and 159.4 billion in 2029, consistently remaining at 6.4 per cent of GDP.
This is a key factor to bear in mind when comparing resources for the National Health Service: a nominal increase in funding does not necessarily equate to a rise in the share of healthcare expenditure relative to the wealth generated. In fact, over the three-year period 2027–2029, healthcare expenditure will rise by an average of 2.4 per cent per year, compared with nominal GDP growth of 2.6 per cent.
The ‘personal’ factor
A significant proportion of the growth in 2026 is also accounted for by staff costs. Income from employment rises to 47.985 billion, up 7.3 per cent, mainly due to the 2025–2027 contract renewals, allowances and other pay rises. Intermediate consumption reaches 49.239 billion (+3.4%), whilst services purchased from private producers rise to 46.747 billion (+4.2%). Of this total, 8.389 billion relates to state-subsidised pharmaceuticals and 7.710 billion to general medical care.

